drugset / Trial / NCT06003348

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

NCT06003348

Phase 4 Recruiting 25 enrolled University of Texas Southwestern Medical Center
RandomizedCrossoverQuadruple-blindPrevention

Summary

This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.

Timeline

Start
2023-12-13
Primary completion
2028-05-31
Completion
2028-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 10 meq Oral

Indications